• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多中心营养饮料降胆固醇研究(评估疗效和耐受性)。

A multicenter study of nutraceutical drinks for cholesterol (evaluating effectiveness and tolerability).

机构信息

Charles E. Schmidt College of Medicine, Florida Atlantic University, 880 NW 13th street, Suite 1B, Boca Raton, FL 33486, USA.

出版信息

J Clin Lipidol. 2012 Mar-Apr;6(2):150-8. doi: 10.1016/j.jacl.2011.09.004. Epub 2011 Sep 21.

DOI:10.1016/j.jacl.2011.09.004
PMID:22385548
Abstract

BACKGROUND

We hypothesized that a nutraceutical formulation containing small amounts of bioactive constituents that exert cholesterol-lowering effects by different mechanisms may exhibit synergistic efficacy with a clean tolerability profile. The purpose of this study was to evaluate nutraceutical fruit-flavored drinks with and without red yeast rice (RYR) for effects on low-density lipoprotein (LDL) and total cholesterol.

METHODS

In double-blinded fashion, 79 subjects were randomized to one of three fruit-flavored drinks, ie, a placebo, and two active drinks containing niacin, phytosterol esters, L-carnitine, vitamin C, and Co-Q-10, one with and without RYR, twice daily. Primary end points were LDL and total cholesterol percent reductions from baseline. Secondary end points were high-density lipoprotein and C-reactive protein percent change from baseline. Physician contact and laboratory work were obtained at baseline, 4 weeks, and 8 weeks of subject participation.

RESULTS

A total of 59 subjects completed the study. The placebo group and the group receiving the nutraceuticals without RYR showed no change in primary or secondary end points. The nutraceutical drink with RYR reduced total cholesterol at week 4 by 13% (-35 mg/dL) and week 8 by 14% (-46 mg/dL). LDL cholesterol decreased 17.1% at 4 weeks (-28 mg/dL) and 17.8% at week 8 (-30 mg/dL). In the effective drink arm containing nutraceuticals and RYR there were no biochemical or subjective intolerance, with the exception of one subject who experienced headache.

CONCLUSIONS

A nutraceutical drink with RYR can be a safe and effective natural alternative to pharmacologic therapies for people intolerant to or refusing statins but still in need of achieving and maintaining a healthy and low cholesterol level.

摘要

背景

我们假设一种含有少量生物活性成分的营养配方,这些成分通过不同的机制发挥降低胆固醇的作用,可能与清洁耐受性有关。本研究的目的是评估含有或不含有红曲米(RYR)的营养水果饮料对低密度脂蛋白(LDL)和总胆固醇的影响。

方法

在双盲的情况下,79 名受试者被随机分为三组水果味饮料,即安慰剂组和两种含有烟酸、植物甾醇酯、左旋肉碱、维生素 C 和 Co-Q-10 的活性饮料,一种含有 RYR,另一种不含有 RYR,每天两次。主要终点是 LDL 和总胆固醇从基线的百分比降低。次要终点是高密度脂蛋白和 C 反应蛋白从基线的百分比变化。在受试者参与的基线、4 周和 8 周时,进行了医生接触和实验室工作。

结果

共有 59 名受试者完成了研究。安慰剂组和不含有 RYR 的营养组在主要和次要终点均无变化。含有 RYR 的营养饮料在第 4 周总胆固醇降低 13%(-35mg/dL),第 8 周降低 14%(-46mg/dL)。LDL 胆固醇在第 4 周降低 17.1%(-28mg/dL),第 8 周降低 17.8%(-30mg/dL)。在含有营养成分和 RYR 的有效饮料组中,除了一名出现头痛的受试者外,没有生化或主观不耐受。

结论

对于不能耐受或拒绝他汀类药物但仍需要达到和维持健康低胆固醇水平的人来说,含有 RYR 的营养饮料可以作为一种安全有效的天然替代药物疗法。

相似文献

1
A multicenter study of nutraceutical drinks for cholesterol (evaluating effectiveness and tolerability).多中心营养饮料降胆固醇研究(评估疗效和耐受性)。
J Clin Lipidol. 2012 Mar-Apr;6(2):150-8. doi: 10.1016/j.jacl.2011.09.004. Epub 2011 Sep 21.
2
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.老年高胆固醇血症患者用营养保健品(小檗碱、红曲米、植物固醇)的长期效果。
Adv Ther. 2011 Dec;28(12):1105-13. doi: 10.1007/s12325-011-0082-5. Epub 2011 Nov 21.
3
Phytosterols, red yeast rice, and lifestyle changes instead of statins: a randomized, double-blinded, placebo-controlled trial.植物固醇、红曲米和生活方式改变而非他汀类药物:一项随机、双盲、安慰剂对照试验。
Am Heart J. 2013 Jul;166(1):187-96. doi: 10.1016/j.ahj.2013.03.019. Epub 2013 Apr 30.
4
Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.在重度高胆固醇血症高危患者中实现脂蛋白目标:依折麦布与阿托伐他汀联合应用的疗效和安全性。
Am Heart J. 2004 Sep;148(3):447-55. doi: 10.1016/j.ahj.2004.03.052.
5
Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.依折麦布/辛伐他汀对原发性高胆固醇血症患者脂蛋白亚组分的影响:使用两种市售技术对存档样本进行的探索性分析。
Clin Ther. 2007 Nov;29(11):2419-32. doi: 10.1016/j.clinthera.2007.10.004.
6
Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.氟伐他汀缓释片(80毫克)单药及与依折麦布(10毫克)联合使用对原发性高胆固醇血症患者低密度脂蛋白胆固醇及炎症参数的影响:一项为期12周的多中心、随机、开放标签、平行组研究。
Clin Ther. 2008 Jan;30(1):84-97. doi: 10.1016/j.linthera.2008.01.013.
7
Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.在老年患者中,依折麦布联合他汀类药物持续治疗对改善血脂谱及实现低密度脂蛋白胆固醇目标的有效性:一项随机、双盲、安慰剂对照试验数据的亚组分析
Am J Geriatr Pharmacother. 2005 Dec;3(4):218-28.
8
A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.一项多中心、随机、双盲、安慰剂对照、析因设计研究,旨在评估依折麦布/辛伐他汀片与依折麦布及辛伐他汀单药治疗相比,在原发性高胆固醇血症患者中的降脂疗效和安全性。
Clin Ther. 2004 Nov;26(11):1758-73. doi: 10.1016/j.clinthera.2004.11.016.
9
Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.在临床实践中测试一种降脂营养保健品的短期疗效:一项多中心研究。
J Med Food. 2015 Nov;18(11):1270-3. doi: 10.1089/jmf.2015.0024. Epub 2015 Aug 14.
10
A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.一项为期52周的随机、开放标签、平行组比较研究,旨在观察匹伐他汀和阿托伐他汀对日本低密度脂蛋白胆固醇水平升高且伴有糖耐量异常患者的高密度脂蛋白胆固醇水平及糖代谢的耐受性和影响。
Clin Ther. 2008 Jun;30(6):1089-101. doi: 10.1016/j.clinthera.2008.05.017.

引用本文的文献

1
Evaluation the effects of red yeast rice in combination with statin on lipid profile and inflammatory indices; a randomized clinical trial.评估红曲米联合他汀类药物对血脂谱和炎症指标的影响;一项随机临床试验。
BMC Nutr. 2022 Nov 25;8(1):138. doi: 10.1186/s40795-022-00639-z.
2
Red Yeast Rice for Hyperlipidemia: A Meta-Analysis of 15 High-Quality Randomized Controlled Trials.红曲米治疗高脂血症:15项高质量随机对照试验的荟萃分析
Front Pharmacol. 2022 Jan 17;12:819482. doi: 10.3389/fphar.2021.819482. eCollection 2021.
3
The effects of L-carnitine supplementation on indicators of inflammation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials.
补充左旋肉碱对炎症和氧化应激指标的影响:随机对照试验的系统评价和荟萃分析
J Diabetes Metab Disord. 2020 Sep 15;19(2):1879-1894. doi: 10.1007/s40200-020-00627-9. eCollection 2020 Dec.
4
Functional food red yeast rice (RYR) for metabolic syndrome amelioration: a review on pros and cons.用于改善代谢综合征的功能性食品红曲米:利弊综述
World J Microbiol Biotechnol. 2016 May;32(5):87. doi: 10.1007/s11274-016-2035-2. Epub 2016 Apr 2.
5
A meta-analysis of red yeast rice: an effective and relatively safe alternative approach for dyslipidemia.红曲米的荟萃分析:一种治疗血脂异常的有效且相对安全的替代方法。
PLoS One. 2014 Jun 4;9(6):e98611. doi: 10.1371/journal.pone.0098611. eCollection 2014.